Please wait a minute...
文章检索
预防医学  2026, Vol. 38 Issue (9): 917-922    DOI: 10.19485/j.cnki.issn2096-5087.2026.09.012
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
老年肺癌化疗患者社会衰弱及影响因素分析
王晴晴1, 刘泓1, 张伟1, 王红彩2, 李旭鸿1, 王一诺1, 张媛媛1
1.山东第二医科大学护理学院,山东 潍坊 261053;
2.山东第二医科大学附属医院,山东 潍坊 261031
Social frailty and its influencing factors among elderly lung cancer patients undergoing chemotherapy
WANG Qingqing1, LIU Hong1, ZHANG Wei1, WANG Hongcai2, LI Xuhong1, WANG Yinuo1, ZHANG Yuanyuan1
1. School of Nursing, Shandong Second Medical University, Weifang, Shandong 261053, China;
2. Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong 261031, China
全文: PDF(898 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解老年肺癌化疗患者社会衰弱现状及影响因素,为制定社会衰弱早期筛查与分级管理策略提供依据。方法 采用方便抽样方法抽取2025年11月—2026年4月在山东省潍坊市某三级甲等医院呼吸内科和肿瘤内科住院的老年肺癌化疗患者为调查对象。通过问卷调查收集人口学信息、生活行为、病理分期和化疗次数等,采用Charlson共病指数、临床衰弱量表、工具性日常生活活动能力量表、患者健康问卷抑郁量表和汉化社会衰弱指数量表分别评估共病负担、躯体衰弱、工具性日常生活活动能力、抑郁症状和社会衰弱。采用多因素logistic回归模型分析老年肺癌化疗患者社会衰弱的影响因素。结果 调查老年肺癌化疗患者249例,其中男性192例,占77.11%;女性57例,占22.89%。年龄为(68.86±5.83)岁。检出社会衰弱73例,检出率为29.32%。多因素logistic回归分析结果显示,初中及以上文化程度(OR=0.171,95%CI:0.031~0.940)、有配偶(OR=0.132,95%CI:0.028~0.634)和工具性日常生活活动能力得分高(OR=0.360,95%CI:0.180~0.721)的老年肺癌化疗患者社会衰弱风险更低,化疗次数≥4次(OR=4.168,95%CI:1.131~15.361)、Charlson共病指数高(OR=4.749,95%CI:2.117~10.653)、躯体衰弱得分高(OR=3.274,95%CI:1.330~8.057)和抑郁症状得分高(OR=2.005,95%CI:1.358~2.961)的老年肺癌化疗患者社会衰弱风险更高。结论 老年肺癌化疗患者社会衰弱检出率较高,文化程度、婚姻状况、化疗次数、共病负担、躯体衰弱、工具性日常生活活动能力和抑郁症状是其影响因素。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
王晴晴
刘泓
张伟
王红彩
李旭鸿
王一诺
张媛媛
关键词 : 肺癌,  化疗,  社会衰弱,  影响因素    
Abstract:Objective To investigate the current status and influencing factors of social frailty among elderly lung cancer patients undergoing chemotherapy, so as to provide evidence for developing early-screening and hierarchical-management strategies for social frailty. Methods From November 2025 to April 2026, hospitalized elderly lung cancer patients undergoing chemotherapy in the Department of Respiratory Medicine and Department of Oncology of a tertiary A hospital in Weifang City, Shandong Province were selected as study participants using convenience sampling method. Data on demographic characteristics, life behaviors, pathological staging, and number of chemotherapy cycles were collected through questionnaire surveys. Comorbidity burden, physical frailty, instrumental activities of daily living capacity, depressive symptoms, and social frailty were assessed using the Charlson Comorbidity Index, Clinical Frailty Scale, Instrumental Activities of Daily Living Scale, Patient Health Questionnaire-9, and Chinese Social Frailty Index Scale, respectively. A multivariable logistic regression model was used to analyze the influencing factors of social frailty among elderly lung cancer patients undergoing chemotherapy. Results A total of 249 elderly lung cancer patients undergoing chemotherapy were surveyed, including 192 males (77.11%) and 57 females (22.89%). The mean age of the participants was (68.86±5.83) years. Social frailty was identified in 73 participants, with a detection rate of 29.32%. Multivariable logistic regression analysis showed that junior high school education level or above (OR=0.171, 95%CI: 0.031-0.940), having a spouse (OR=0.132, 95%CI: 0.028-0.634), and higher scores of instrumental activities of daily living capacity (OR=0.360, 95%CI: 0.180-0.721) had a lower risk of social frailty; number of chemotherapy cycles ≥4 (OR=4.168, 95%CI: 1.131-15.361), higher Charlson Comorbidity Index (OR=4.749, 95%CI: 2.117-10.653), higher physical frailty scores (OR=3.274, 95%CI: 1.330-8.057), and higher depressive symptom scores (OR=2.005, 95%CI: 1.358-2.961) had a higher risk of social frailty. Conclusions The detection rate of social frailty among elderly lung cancer patients undergoing chemotherapy was relatively high. Education level, marital status, number of chemotherapy cycles, comorbidity burden, physical frailty, instrumental activities of daily living capacity and depressive symptoms were the influencing factors of social frailty among elderly patients with lung cancer undergoing chemotherapy.
Key words: lung cancer    chemotherapy    social frailty    influencing factor
收稿日期: 2026-07-10      修回日期: 2026-08-29     
中图分类号:  R734.2  
基金资助:山东省自然科学基金项目(ZR2024QG232)
作者简介: 王晴晴,硕士研究生在读,护理专业
通信作者: 张媛媛,E-mail:Yixue1068@163.com   
引用本文:   
王晴晴, 刘泓, 张伟, 王红彩, 李旭鸿, 王一诺, 张媛媛. 老年肺癌化疗患者社会衰弱及影响因素分析[J]. 预防医学, 2026, 38(9): 917-922.
WANG Qingqing, LIU Hong, ZHANG Wei, WANG Hongcai, LI Xuhong, WANG Yinuo, ZHANG Yuanyuan. Social frailty and its influencing factors among elderly lung cancer patients undergoing chemotherapy. Preventive Medicine, 2026, 38(9): 917-922.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2026.09.012      或      https://www.zjyfyxzz.com/CN/Y2026/V38/I9/917
[1] Xia C F,Li H,Wu C,et al.Cancer burden and control in China:landscape,trends and challenges[J].Nat Rev Clin Oncol,2026,23(9):694-711.
[2] 罗钰,杨雪,王力.肺癌化疗患者认知功能障碍现状及影响因素分析[J].华西医学,2025,40(5):722-727.
[3] Wang C,Qiu X K,Yang X L,et al.Factors influencing social isolation among cancer patients:a systematic review[J/OL].Healthcare (Basel),2024,12(10)[2026-08-29].https://doi.org/10.3390/healthcare12101042.
[4] Bunt S,Steverink N,Olthof J,et al.Social frailty in older adults:a scoping review[J].Eur J Ageing,2017,14(3):323-334.
[5] Zhang H,Hao M,Hu Z X,et al.Social frailty and its association with cognitive trajectories in older adults:a prospective cohort study[J/OL].Alzheimers Res Ther,2025,17(1)[2026-08-29].https://doi.org/10.1186/s13195-025-01687-w.
[6] Yamada M,Arai H.Social frailty predicts incident disability and mortality among community-dwelling Japanese older adults[J].J Am Med Dir Assoc,2018,19(12):1099-1103.
[7] Shah S J,Oreper S,Jeon S Y,et al.Social Frailty Index:development and validation of an index of social attributes predictive of mortality in older adults[J/OL].Proc Natl Acad Sci U S A,2023,120(7)[2026-08-29].https://doi.org/10.1073/pnas.2209414120.
[8] Møller J K,la Cour K,Pilegaard M S,et al.Social vulnerability among cancer patients and changes in vulnerability during their trajectories-a longitudinal population-based study[J/OL].Cancer Epidemiol,2023,85[2026-08-29].https://doi.org/10.1016/j.canep.2023.102401
[9] Charlson M E,Pompei P,Ales K L,et al.A new method of classifying prognostic comorbidity in longitudinal studies:development and validation[J].J Chronic Dis,1987,40(5):373-383.
[10] Rockwood K,Song X W,MacKnight C,et al.A global clinical measure of fitness and frailty in elderly people[J].CMAJ,2005,173(5):489-495.
[11] Fillenbaum G G,Smyer M A.The development,validity,and reliability of the oars multidimensional functional assessment questionnaire[J].J Gerontol,1981,36(4):428-434.
[12] Kroenke K,Spitzer R L,Williams J B.The PHQ-9:validity of a brief depression severity measure[J].J Gen Intern Med,2001,16(9):606-613.
[13] 张露露,高静,吴晨曦,等.社会衰弱指数量表的汉化及信效度检验[J].护理学杂志,2023,38(8):102-105.
[14] 于珊,车雅洁,苏比伊努尔·麦麦提,等.城乡老年人社会衰弱现状及对比研究[J].护理学杂志,2025,40(15):6-12.
[15] 彭心雨,宋明方,张婉,等.社区老年人社会衰弱现状及影响因素[J].护理研究,2021,35(19):3401-3406.
[16] Hegde M,Daimary U D,Girisa S,et al.Tumor cell anabolism and host tissue catabolism-energetic inefficiency during cancer cachexia[J].Exp Biol Med (Maywood),2022,247(9):713-733.
[17] 贾茜茜,任树风,杨雪霞,等.基于健康社会决定因素模型的社区老年慢性疾病患者社会衰弱影响因素研究[J].中国医药导报,2026,23(10):28-33.
[18] Zhang D H,Zheng W H,Li K Y.The relationship between marital status and cognitive impairment in Chinese older adults:the multiple mediating effects of social support and depression[J/OL].BMC Geriatr,2024,24(1)[2026-08-29].https://doi.org/10.1186/s12877-024-04975-6.
[19] Mehrabi F,Pomeroy M L,Cudjoe T K M,et al.The temporal sequence and reciprocal relationships of frailty,social isolation and loneliness in older adults across 21 years[J/OL].Age Ageing,2024,53(10)[2026-08-29].https://doi.org/10.1093/ageing/afae215.
[20] 乔丽敏,赵雅宁,刘瑶,等.老年轻型缺血性脑卒中患者社会衰弱的影响因素及护理启示[J].中华护理杂志,2025,60(10):1251-1256.
[21] 袁艳玲,刘燕,王娜,等.中老年慢性病患者社会隔离与抑郁的发展轨迹及关系研究[J].护理学杂志,2026,41(1):93-97.
[1] 李建云, 吴颖涵, 杨云娟, 戴琳纾, 李慧瑜, 魏依蕾. 云南省中小学生伤害发生的横断面研究[J]. 预防医学, 2026, 38(9): 865-869.
[2] 黄文, 祝彩琴, 黄敏钢, 许璐璐, 陈康康, 王柯颖, 陈国江, 陈奇峰. 绍兴市老年人跌倒的现况调查[J]. 预防医学, 2026, 38(9): 875-879.
[3] 张若娣, 杨利, 滕楠, 陈腾伟, 许圆圆. 初治成功肺结核患者复发的影响因素分析[J]. 预防医学, 2026, 38(9): 886-889,894.
[4] 孙靓, 刘影, 戴威, 张婷, 薛锦锋, 苏凤华. 东城区医务人员干眼症的横断面研究[J]. 预防医学, 2026, 38(9): 945-949.
[5] 袁芳, 张爱平. 江北区居民高血压、糖尿病和血脂异常共病现状及影响因素研究[J]. 预防医学, 2026, 38(8): 815-818,823.
[6] 王红林, 赵丽, 邓峰. 宝鸡市成年居民超重肥胖的流行现状及影响因素[J]. 预防医学, 2026, 38(8): 785-789.
[7] 卢烨, 余红. 青少年特发性脊柱侧凸发病机制和影响因素研究进展[J]. 预防医学, 2026, 38(8): 794-799.
[8] 沈新秀, 周权, 雷静, 戴思芸, 肖春, 林仲. 中老年糖尿病患者视网膜病变的影响因素分析[J]. 预防医学, 2026, 38(8): 800-804.
[9] 张慧慧, 赵娥, 孙高峰, 张明东, 糜建雄. 乌鲁木齐市居民高血压与糖尿病共病现况调查[J]. 预防医学, 2026, 38(7): 652-656.
[10] 赵玲慧, 凌洁, 徐漪, 曹敏忆. 嘉兴市社区老年人痴呆现况调查[J]. 预防医学, 2026, 38(7): 671-674.
[11] 任露露, 闵艺璇, 顾嘉昌, 张思晨, 乔健健, 胡静. 2013—2022年宜兴市肺癌发病和死亡变化趋势分析[J]. 预防医学, 2026, 38(7): 675-679,685.
[12] 江学奇, 陈同, 林相, 车洋, 林律, 桑国鑫, 王奕楠, 张栋梁. 宁波市肺结核患者确诊延迟分析[J]. 预防医学, 2026, 38(7): 699-702.
[13] 马宗康, 叶锦, 樊娇, 蔡美怡, 齐韵菡, 陈凤辉. 老年高血压住院患者主动健康行为的潜在剖面分析[J]. 预防医学, 2026, 38(7): 680-685.
[14] 余敏, 冯云珠, 苗姗姗, 陈慧. 新疆生产建设兵团居民癌症防治素养水平及影响因素分析[J]. 预防医学, 2026, 38(7): 739-742.
[15] 王晓杰, 翁士仲, 王逢慧, 陈德劭, 胡叙萍. 泰顺县居民慢性病防控核心信息知晓情况调查[J]. 预防医学, 2026, 38(7): 735-738.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed